Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro

Antiviral Research

Volumn 115, Issue , 2015, Pages 39-47

  Jardim, A C G ^a,b   Igloi, Z ^c   Shimizu, J F ^b   Santos, V A F F M ^b   Felippe, L G ^b   Mazzeu, B F ^b   Amako, Y ^d   Furlan, M ^b   Harris, M ^c   Rahal, P ^b  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Antiviral; Brazilian plants; Hepatitis C virus; Natural compounds; Replication

Indexed keywords

ALKALOID; ANTIVIRUS AGENT; DACLATASVIR; FIREFLY LUCIFERASE; LIGNAN DERIVATIVE; NATURAL PRODUCT; PLANT MEDICINAL PRODUCT; LIGNAN;

ANTIVIRAL ACTIVITY; ARTICLE; BRAZIL; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; HEPATITIS C VIRUS; HEPATITIS C VIRUS SUBTYPE 1B; HEPATITIS C VIRUS SUBTYPE 2A; HEPATITIS C VIRUS SUBTYPE 3A; IN VITRO STUDY; MAYTRENUS ILICIFOLIA; NONHUMAN; PEPEROMIA; PEPEROMIA BLANDA; PIPER (PLANT); PIPER FULIGINEUM; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENOME; VIRUS REPLICATION; CHEMISTRY; DRUG EFFECTS; GENOTYPE; HEPACIVIRUS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; PLANT; REPLICON; TUMOR CELL LINE;

HEPATITIS C VIRUS; PEPEROMIA;

ALKALOIDS; ANTIVIRAL AGENTS; BRAZIL; CELL LINE, TUMOR; GENOTYPE; HEPACIVIRUS; HUMANS; LIGNANS; MICROBIAL SENSITIVITY TESTS; PEPEROMIA; PIPER; PLANTS; REPLICON; VIRUS REPLICATION;

EID: 84921058941     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.12.018     Document Type: Article

References (46)

1. A. Ahmed-Belkacem, N. Ahnou, L. Barbotte, C. Wychowski, C. Pallier, R. Brillet, R.T. Pohl, and J.M. Pawlotsky Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase Gastroenterology 138 2010 1112 1122
2. M.J. Alter Epidemiology of hepatitis C virus infection World J. Gastroenterol. 13 2007 2436 2441
3. L. Bachmetov, M. Gal-Tanamy, A. Shapira, M. Vorobeychik, T. Giterman-Galam, P. Sathiyamoorthy, A. Golan-Goldhirsh, I. Benhar, R. Tur-Kaspa, and R. Zemel Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity J. Viral Hepatol. 19 2012 e81 e88
4. N. Calland, J. Dubuisson, Y. Rouillé, and K. Séron Hepatitis C virus and natural compounds: a new antiviral approach? Viruses 4 2012 2197 2217
5. Y. Chen, J. Li, M. Zeng, L. Lu, D. Qu, Y. Mao, Z. Fan, and J. Hua The inhibitory effect of oxymatrine on hepatitis C virus in vitro Zhonghua Gan Zang Bing Za Zhi 9 Suppl. 2001 12 14
6. S. Chevaliez, and J.M. Pawlotsky Hepatitis C virus: virology, diagnosis and management of antiviral therapy World J. Gastroenterol. 13 2007 2461 2466
7. M. Choi, Y.M. Kim, S. Lee, Y.W. Chin, and C. Lee Mangosteen xanthones suppress hepatitis C virus genome replication Virus Genes 49 2014 208 222
8. P.M. Costa, P.M. Ferreira, S. Bolzani Vda, M. Furlan, V.A. de Freitas Formenton Macedo Dos Santos, J. Corsino, M.O. de Moraes, L.V. Costa-Lotufo, R.C. Montenegro, and C. Pessoa Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells Toxicol. In Vitro 22 2008 854 863
9. V.A. Dos Santos, K.M. Leite, M. da Costa Siqueira, L.O. Regasini, I. Martinez, C.T. Nogueira, M.K. Galuppo, B.S. Stolf, A.M. Pereira, R.M. Cicarelli, M. Furlan, and M.A. Graminha Antiprotozoal activity of quinonemethide triterpenes from Maytenus ilicifolia (Celastraceae) Molecules 18 2013 1053 1062
10. M.C. Duarte, G.M. Figueira, A. Sartoratto, V.L. Rehder, and C. Delarmelina Anti-Candida activity of Brazilian medicinal plants J. Ethnopharmacol. 97 2005 305 311
11. L.G. Felippe, D.C. Baldoqui, M.J. Kato, S. Bolzani Vda, E.F. Guimaraes, R.M. Cicarelli, and M. Furlan Trypanocidal tetrahydrofuran lignans from Peperomia blanda Phytochemistry 69 2008 445 450
12. L.G. Felippe, J.M. Batista Jr., D.C. Baldoqui, I.R. Nascimento, M.J. Kato, Y. He, L.A. Nafie, and M. Furlan VCD to determine absolute configuration of natural product molecules: secolignans from Peperomia blanda Org. Biomol. Chem. 10 2012 4208 4214
13. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, F.L. Goncales Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N. Engl. J. Med. 347 2002 975 982
14. M. Gao, R.E. Nettles, M. Belema, L.B. Snyder, V.N. Nguyen, R.A. Fridell, M.H. Serrano-Wu, D.R. Langley, J.H. Sun, D.R. O'Boyle 2nd, J.A. Lemm, C. Wang, J.O. Knipe, C. Chien, R.J. Colonno, D.M. Grasela, N.A. Meanwell, and L.G. Hamann Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Nature 465 2010 96 100
15. O. Gonzalez, V. Fontanes, S. Raychaudhuri, R. Loo, J. Loo, V. Arumugaswami, R. Sun, A. Dasgupta, and S.W. French The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production Hepatology 50 2009 1756 1764
16. J. Guedj, H. Dahari, L. Rong, N.D. Sansone, R.E. Nettles, S.J. Cotler, T.J. Layden, S.L. Uprichard, and A.S. Perelson Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life Proc. Natl. Acad. Sci. USA 110 2013 3991 3996
17. F.P. Gullo, J.C. Sardi, V.A. Santos, F. Sangalli-Leite, N.S. Pitangui, S.A. Rossi, E.S.A.C. de Paula, L.A. Soares, J.F. Silva, H.C. Oliveira, M. Furlan, D.H. Silva, V.S. Bolzani, M.J. Mendes-Giannini, and A.M. Fusco-Almeida Antifungal activity of maytenin and pristimerin Evid. Based Complement Alternat. Med. 2012 2012 340787
18. S.J. Hadziyannis, H. Sette Jr., T.R. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Bodenheimer Jr., D. Bernstein, M. Rizzetto, S. Zeuzem, P.J. Pockros, A. Lin, and A.M. Ackrill Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann. Intern. Med. 140 2004 346 355
19. S. Haid, A. Novodomska, J. Gentzsch, C. Grethe, S. Geuenich, D. Bankwitz, P. Chhatwal, B. Jannack, T. Hennebelle, F. Bailleul, O.T. Keppler, M. Poenisch, R. Bartenschlager, C. Hernandez, M. Lemasson, A.R. Rosenberg, F. Wong-Staal, E. Davioud-Charvet, and T. Pietschmann A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes Gastroenterology 143 213-222 2012 e215
20. S.D. Huang, Y. Zhang, M.M. Cao, Y.T. Di, G.H. Tang, Z.G. Peng, J.D. Jiang, H.P. He, and X.J. Hao Myriberine A, a new alkaloid with an unprecedented heteropentacyclic skeleton from Myrioneuron faberi Org. Lett. 15 2013 590 593
21. G. Hussein, H. Miyashiro, N. Nakamura, M. Hattori, N. Kakiuchi, and K. Shimotohno Inhibitory effects of sudanese medicinal plant extracts on hepatitis C virus (HCV) protease Phytother. Res. 14 2000 510 516
22. K. Kitazato, Y. Wang, and N. Kobayashi Viral infectious disease and natural products with antiviral activity Drug Discoveries Ther. 1 2007
23. K.H. Lan, Y.W. Wang, W.P. Lee, K.L. Lan, S.H. Tseng, L.R. Hung, S.H. Yen, H.C. Lin, and S.D. Lee Multiple effects of Honokiol on the life cycle of hepatitis C virus Liver Int. 32 2012 989 997
24. J.A. Lemm, D. O'Boyle 2nd, M. Liu, P.T. Nower, R. Colonno, M.S. Deshpande, L.B. Snyder, S.W. Martin, D.R. St Laurent, M.H. Serrano-Wu, J.L. Romine, N.A. Meanwell, and M. Gao Identification of hepatitis C virus NS5A inhibitors J. Virol. 84 2010 482 491
25. J. Liu, Y. Liu, and C.D. Klaassen The effect of Chinese hepatoprotective medicines on experimental liver injury in mice J. Ethnopharmacol. 42 1994 183 191
26. R.K. Lyn, D.C. Kennedy, S.M. Sagan, D.R. Blais, Y. Rouleau, A.F. Pegoraro, X.S. Xie, A. Stolow, and J.P. Pezacki Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism Virology 394 2009 130 142
27. A. Macdonald, K. Crowder, A. Street, C. McCormick, K. Saksela, and M. Harris The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signaling J. Biol. Chem. 278 2003 17775 17784
28. J. Mann Natural products in cancer chemotherapy: past, present and future Nat. Rev. Cancer 2 2002 143 148
29. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman, R. Reindollar, Z.D. Goodman, K. Koury, M. Ling, and J.K. Albrecht Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
30. J.M. Pawlotsky New hepatitis C therapies: the toolbox, strategies, and challenges Gastroenterology 146 2014 1176 1192
31. S.J. Polyak, C. Morishima, M.C. Shuhart, C.C. Wang, Y. Liu, and D.Y. Lee Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin Gastroenterology 132 2007 1925 1936
32. S.J. Polyak, C. Morishima, V. Lohmann, S. Pal, D.Y. Lee, Y. Liu, T.N. Graf, and N.H. Oberlies Identification of hepatoprotective flavonolignans from silymarin Proc. Natl. Acad. Sci. USA 107 2010 5995 5999
33. G. Rinck, C. Birghan, T. Harada, G. Meyers, H.J. Thiel, and N. Tautz A cellular J-domain protein modulates polyprotein processing and cytopathogenicity of a pestivirus J. Virol. 75 2001 9470 9482
34. D. Ross-Thriepland, and M. Harris Insights into the complexity and functionality of hepatitis C virus NS5A phosphorylation J. Virol. 88 2014 1421 1432
35. M. Saeed, T.K. Scheel, J.M. Gottwein, S. Marukian, L.B. Dustin, J. Bukh, and C.M. Rice Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells Antimicrob. Agents Chemother. 56 2012 5365 5373
36. I. Saito, T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, and Y. Ohta Hepatitis C virus infection is associated with the development of hepatocellular carcinoma Proc. Natl. Acad. Sci. USA 87 1990 6547 6549
37. V.A. Santos, L.O. Regasini, C.R. Nogueira, G.D. Passerini, I. Martinez, V.S. Bolzani, M.A. Graminha, R.M. Cicarelli, and M. Furlan Antiprotozoal sesquiterpene pyridine alkaloids from Maytenus ilicifolia J. Nat. Prod. 75 2012 991 995
38. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect. Dis. 5 2005 558 567
39. P. Targett-Adams, and J. McLauchlan Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon J. Gen. Virol. 86 2005 3075 3080
40. D.M. Tscherne, C.T. Jones, M.J. Evans, B.D. Lindenbach, J.A. McKeating, and C.M. Rice Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry J. Virol. 80 2006 1734 1741
41. J. Wagoner, A. Negash, O.J. Kane, L.E. Martinez, Y. Nahmias, N. Bourne, D.M. Owen, J. Grove, C. Brimacombe, J.A. McKeating, E.I. Pecheur, T.N. Graf, N.H. Oberlies, V. Lohmann, F. Cao, J.E. Tavis, and S.J. Polyak Multiple effects of silymarin on the hepatitis C virus lifecycle Hepatology 51 2010 1912 1921
42. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.G. Krausslich, M. Mizokami, R. Bartenschlager, and T.J. Liang Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 11 2005 791 796
43. S.F. Wu, C.K. Lin, Y.S. Chuang, F.R. Chang, C.K. Tseng, Y.C. Wu, and J.C. Lee Anti-hepatitis C virus activity of 3-hydroxy caruilignan C from Swietenia macrophylla stems J. Viral Hepatol. 19 2012 364 370
44. D.L. Wyles, K.A. Kaihara, F. Vaida, and R.T. Schooley Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets J. Virol. 81 2007 3005 3008
45. D.L. Wyles, K.A. Kaihara, B.E. Korba, R.T. Schooley, J.R. Beadle, and K.Y. Hostetler The octadecyloxyethyl ester of (S)-9-[3-hydroxy-2-(phosphonomethoxy) propyl]adenine is a potent and selective inhibitor of hepatitis C virus replication in genotype 1A, 1B, and 2A replicons Antimicrob. Agents Chemother. 53 2009 2660 2662
46. Z. Yi, L. Sperzel, C. Nurnberger, P.J. Bredenbeek, K.J. Lubick, S.M. Best, C.T. Stoyanov, L.M. Law, Z. Yuan, C.M. Rice, and M.R. MacDonald Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator PLoS Pathog. 7 2011 e1001255